12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga · 06/12 12:07
Gainers
- Healthcare Triangle (NASDAQ:HCTI) stock increased by 115.2% to $0.02 during Thursday's pre-market session. The company's market cap stands at $8.0 million.
- Liminatus Pharma (NASDAQ:LIMN) stock rose 31.32% to $14.59. The market value of their outstanding shares is at $379.5 million.
- Klotho Neurosciences (NASDAQ:KLTO) stock moved upwards by 19.31% to $1.73. The company's market cap stands at $56.2 million.
- NewGenIvf Group (NASDAQ:NIVF) shares rose 15.15% to $2.28. The market value of their outstanding shares is at $2.3 million.
- Wellgistics Health (NASDAQ:WGRX) stock moved upwards by 14.78% to $1.63. The market value of their outstanding shares is at $117.1 million.
- TherapeuticsMD (NASDAQ:TXMD) stock rose 11.66% to $1.34. The company's market cap stands at $15.5 million.
Losers
- Intensity Therapeutics (NASDAQ:INTS) shares decreased by 48.7% to $0.3 during Thursday's pre-market session. The market value of their outstanding shares is at $5.4 million.
- Helius Medical Tech (NASDAQ:HSDT) stock decreased by 39.93% to $0.67.
- Catheter Precision (AMEX:VTAK) stock decreased by 26.68% to $0.44. The market value of their outstanding shares is at $4.8 million.
- Jupiter Neurosciences (NASDAQ:JUNS) shares decreased by 22.62% to $1.54. The market value of their outstanding shares is at $50.9 million.
- Tonix Pharmaceuticals (NASDAQ:TNXP) stock declined by 22.28% to $29.31. The company's market cap stands at $214.6 million.
- Nuwellis (NASDAQ:NUWE) shares decreased by 13.83% to $0.32. The company's market cap stands at $1.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.